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Ghrelin, a peptide hormone secreted by the stomach, has been shown to regulate energy homeostasis by modulating electrical
activity of neurons in the central nervous system (CNS). Like many circulating satiety signals, ghrelin is a peptide hormone and
is unable to cross the blood-brain barrier without a transport mechanism. In this review, we address the notion that the arcuate
nucleus of the hypothalamus is the only site in the CNS that detects circulating ghrelin to trigger orexigenic responses. We consider
the roles of a specialized group of CNS structures called the sensory circumventricular organs (CVOs), which are not protected
by the blood-brain barrier. These areas include the subfornical organ and the area postrema and are already well known to be key
areas for detection of other circulating hormones such as angiotensin II, cholecystokinin, and amylin. A growing body of evidence
indicates a key role for the sensory CVOs in the regulation of energy homeostasis.
1.Introduction
Prior to 1999, the growth hormone secretagogue receptor
(GHS-R)wasanorphanreceptor,knowntoevoketherelease
of growth hormone via a pathway independent of GHRH.
The work of Kojima et al. [1] identiﬁed ghrelin, a 28-amino
acid peptide secreted by the stomach, as the endogenous lig-
and for the GHS-R. Several facts immediately suggested that
ghrelin might be involved in regulation of energy balance.
First, ghrelin was secreted by the X/A-like cells in the fundus
of the stomach and secretion was elevated with fasting [2],
thus providing a clear signal from the gut regarding energy
status. Second, it had previously been established that small
molecule or peptide growth hormone secretagogues (GHSs)
which activate the GHS-R also stimulated feeding [3]. Lastly,
theobservationthattheGHS-Rwasstronglyexpressedinthe
NPY neurons of arcuate nucleus of the hypothalamus (ARC)
[4, 5] suggested this as a potential central nervous system site
of action for this peptide. In 2000, Tschop et al. [2]c l e a r l y
demonstrated that ghrelin stimulated feeding and adiposity
in mice and rats. Later, Cowley et al. [6] showed that ghrelin
mediated activation of the GHS-R in ARC and eﬀects which
in turn modulated the electrical activity of the NPY and
POMC neurons that had already been established as critical
regulators of feeding behavior. These and similar results
stimulated a great deal of interest because understanding the
ghrelin signaling pathway was identiﬁed as a potential route
in the development of successfulstrategies for the prevention
and treatment of obesity. In spite of the overwhelming
evidence that ghrelin stimulates feeding and adiposity, there
is still controversy as to ghrelin’s ultimate site of orexigenic
activity within the CNS. This review aims to highlight some
of the contentious points and to suggest some alternative
explanations for the available data to this point in time.
2.HypothalamicActions of Ghrelinin
the Regulation of Food Intake
The GHS-R is widely expressed in the body, being found in
the brain, stomach, intestine, pancreas, heart, and gonads
[7]. The density of the receptor is especially high in the
pituitary, ARC, and dorsal vagal complex (DVC), including
the area postrema (AP), the nucleus of the solitary tract2 International Journal of Pediatrics
(NTS), and the dorsal motor nucleus of the vagus (DMV)
[8–12]. The high levels of expression of the GHS-R within
the ARC and the fact that ghrelin-producing neurons have
been discovered in the hypothalamus [6]s t r o n g l ys u g g e s t
that ghrelin plays a role in feeding. Indeed, a role for ghrelin
inregulating food intake andenergystores drawsstrong sup-
port from a wide variety of diﬀerent studies. Microinjections
of ghrelin into the ARC as well as intracerebroventricular
(ICV) injections of ghrelin strongly stimulated weight gain
and feeding in rats and mice [2, 13–17]. Similar injections
activated NPY and AGRP neurons within the ARC, as deter-
mined by c-Fos immunolabeling [16–18]. Ghrelin receptors
are highly localized on NPY neurons [4, 5, 19], and direct
application of the hormone in patch-clamp experiments
increased their electrical activity [6, 20, 21]. Similar results
were observed using real time quantitative Ca++ imaging
[22] and single unit recordings [23]. Perhaps some of the
strongest evidence that ghrelin regulates food intake via its
actioninthehypothalamusisthatlesioningtheARCresulted
in loss of appetite-stimulating eﬀects of both peripheral and
ICV ghrelin [24, 25]. Moreover, genetic manipulations in
mice clearly show that deleting NPY reduces the eﬀect of
administered ghrelin, whereas deleting both NPY and AGRP
completely abolishes the orexigenic response to ghrelin [26].
But does circulating ghrelin regulate energy balance as
a direct consequence of primary eﬀects on the electrical
activity of ARC neurons? Although the prevailing view in
the literature is a very deﬁnitive “yes”, we believe that this
supposition may deserve some careful examination in view
of some recent studies we will describe below. The fact
that peripherally injected ghrelin not only causes weight
gain and feeding [2, 15, 27, 28] but also increases c-Fos
immunolabeling in the ARC, paraventricular nucleus and
other areas [29–32] represent the primary data resulting in
the conclusion that ghrelin directly modulates the electrical
activity of GHS-R expressing neurons within the ARC by
somehow crossing the blood-brain barrier (BBB), which
despite alternative suggestions does exist in this region of the
brain [33]. The critical issue to a true understanding of the
mechanisms underlying central actions of ghrelin, we would
suggest, is a clear description of how circulating ghrelin
gets to and thus inﬂuences the activity of ARC and other
CNS neurons involved in the regulation of energy balance.
An u m b e ro fd i ﬀerent mechanisms have been suggested.
3.TransendothelialCellSignaling
The neurons of the CNS are privileged in that they are
protected by the BBB. It is well recognized that lipophobic
molecules such as peptide hormones cannot cross the
BBB by simple diﬀusion. Instead, such molecules can only
communicate with neurons on the other side through
limited routes. One route is indirect, involving binding of a
circulating peptide signal to the luminal side of endothelial
cells, which then produce diﬀusible messengers on the
abluminal side [34, 35]. Gaskin et al. [36] have indeed
shown that ICV injections of ghrelin stimulate synthesis of
the diﬀusible messenger nitric oxide (NO), which in turn
stimulates feeding. However in delivery by ICV injection,
many experiments bypassed the function of the BBB. Thus
the questions of whether and how ghrelin crosses the BBB
still remain.
4.SpecializedTransporters
Another route of communication across the BBB which has
been suggested to play a role in blood-brain communication
for other peptides involves the existence of specialized
saturable transport mechanisms. Such transporters are able
to move water soluble molecule across the BBB such that
when released into the CNS side of the barrier these
molecules directly contact with the neurons expressing the
cognate receptors. Such transport mechanisms exist for
glucose [37] and leptin although the transporter protein
for leptin remains elusive (for review see [38]). Transport
of circulating ghrelin across the BBB has been investigated
[39–41]. Banks et al. [39] demonstrated in mice that a
saturable transport system exists for transporting ghrelin
from the brain to the circulation; however, no such system
was identiﬁed for blood to brain transport. Interestingly,
human ghrelin, which diﬀers from mouse ghrelin by two
amino acids, was a substrate for both directions of transport.
Therefore while the data are suggestive, the fact that only
ghrelin from another species could be transported across
mouse BBB suggests that some caution should be accorded
to the conclusion that a speciﬁc ghrelin transporter is
responsible for transport of this peptide from the circulation
to the direct milieu surrounding ARC neurons.
A further consideration with regard to the role of such
a speciﬁc transporter, if it does exist, relates to the rate of
transport. The plasma/CSF ratio is usually quite low, in the
4%–7% range for leptin, for example [38], and with typical
concentration for ghrelin in the serum of approximately
1–3nM [2, 15], which would translate into a transporter-
mediated CSF level of about 50–150pM. While the IC50
for the cloned GHS-R is reported to be 0.19–32nM [42,
43] the observed IC50 values for studies examining the
electrophysiological eﬀects of ghrelin applied to neurons
have been in the 1nM to 14nM range [44–46]. This suggests
that the concentration of ghrelin found in the CSF due to
a putative transport mechanism might not actually be high
enough to elicit signiﬁcant changes in neuronal electrical
activity. Indeed, a recent investigation of plasma/CSF ratios
in sheep indicated that a ten-fold increase in circulating
ghrelin levels (achieved by peripheral injection) required
some 40–50 minutes to increase CSF ghrelin concentrations
two-fold. Moreover, the normal concentration of ghrelin in
the CSF was 1000-fold lower than in the circulation [47].
Again, the CSF concentration appears for the most part to
be much lower than the EC50 for the GHS-R.
5.The Blood-Brain Barrierin
the Arcuate Nucleus
In the absence of a specialized mechanism to transport
ghrelin, some have suggested that circulating ghrelin directlyInternational Journal of Pediatrics 3
accesses ARC neurons as the result of this region being
endowed with a weak or modiﬁed BBB [30, 48, 49]. Others
assert that the ARC has no blood-brain barrier at all [14]
or that blood borne molecules can leak from the median
eminence to the ARC [32]. However, anatomical evidence
indicatesthattheARCdemonstratesBBBintegrityconsistent
with that found in other secure locations [33, 50–52]. In fact
a classic study using IV injection of horseradish peroxidase
to delineate areas with no BBB clearly indicated that the
BBB of ARC is similar to that of other adjacent areas
[53]. Only after eight hours of incubation is HRP staining
product observable this being due to retrograde transport
from axonal projections to median eminence. Further work
by Broadwell et al. [54] demonstrated that IV injection of
horseradish peroxidase resulted in reaction product almost
entirely limited to median eminence with little evidence of
entrytoARCviathisroute.Lastly,leakageofghrelinfromthe
medianeminencethroughtheparenchymaandintotheARC
too is highly unlikely. The median eminence is segregated
fromtheneuropilbyalayeroftanacyteswhichareconnected
by tight junctions [55] which provide a formidable barrier
against movement of solute. Also, diﬀusion through brain
tissue is limited [38, 56], as the rate is inversely proportional
to the square of the distance.
Elevated levels of c-Fos immunostaining in the ARC
after peripheral injection have been suggested to support
the notion that ghrelin can cross the BBB (of the ARC)
and modulate activity of neurons in ARC, which may
in turn modulate activity in other brain areas [31, 32].
However, unless speciﬁcally designed to do so, neither c-Fos
immunostaining studies can resolve order of activation of
the areas showing increased neuronal activity nor can such
studies show when ghrelin inhibits neuronal activity (see
[44,57]).Indeed,Dateetal.[58]provideevidencesuggesting
thatactivationofARCneuronsandtheobservedincreasedc-
Fos immunostaining in ARC induced by peripheral injection
may be secondary to activation of vagal aﬀerents and/or
neurons within the NTS.
While there is no doubt that neurons of the ARC and
elsewhere do respond to peripheral ghrelin administration, a
mechanismbywhichendogenouscirculatingghrelinactually
binds to and activates the GHS-Rs found on neurons in the
ARC and elsewhere in the hypothalamus is presently unclear.
6. AreThere Other AreasWhere GhrelinCan
DirectlyBind to Neurons ExpressingGHS-R?
Sensory circumventricular organs (CVOs) are specialized
areas of the CNS that lack the normal BBB and allow ghrelin
and other peptides to bind peptidergic receptors on neurons.
UnlikethecapillariesofmostareasoftheCNS,thecapillaries
of the sensory CVOs have fenestrations similar to those
foundintheperiphery,andthecapillariesarenotenclosedby
a layer of glia cell end feet. The circulation within the sensory
CVOs is also specialized to facilitate detection of circulating
solutes: the capillary beds are dense and exhibit tortuosities
that slow blood ﬂow and “Virchow-Robin spaces” that allow
interstitial ﬂuid to pool around the capillaries [59]( f o ra
complete review see [60]). Sensory CVOs are particularly
well endowed with a high density and wide variety of
peptidergic receptors. Lastly, the sensory CVOs have strong
connections to a variety of autonomic control centers. Thus
the sensory CVOs act as transducers to detect signals within
the circulation and communicate this information to other
centers of the CNS for integration and processing. There
are three sensory CVOs: the subfornical organ (SFO), area
postrema (AP), and the organum vasculosum of the lamina
terminalis (OVLT). Both the SFO and the AP are known to
express the GHS-R and to contain ghrelin-sensitive neurons;
there have not been data suggesting that the OVLT plays a
role in the detection of ghrelin.
The SFO projects from the rostral wall into the third
ventricle and is located dorsally to the lamina terminalis.
It sends direct and indirect projections to vasopressin and
oxytocin neurons of the paraventricular nucleus and the
supraoptic nucleus of the hypothalamus [61]. The SFO also
sends projections to the parvocellular neurons of the PVN
[62], the ARC [63, 64], and other areas of the hypothalamus.
Aﬀerent projections to the SFO include the NTS, the lateral
hypothalamus, the midbrain raphe, and other areas [64–
66]. Thus, the SFO is in direct contact with ghrelin in the
circulation and communicates with key autonomic control
centers.
The AP is located in the fourth ventricle, on the dorsal
surface of the medulla positioned adjacent to the NTS.
The AP together with the NTS and DMV makes up the
dorsal vagal complex, a major site for integration of aﬀerent
information from the gut, viscera, and circulation. The AP
has reciprocal connections with a variety of targets; most
notably are the NTS, the lateral parabrachial nucleus, the
nucleus ambiguus, and the tegmental nuclei [67, 68]. There
are also descending connections from the PVN to AP [69].
Of particular interest, however, both the NTS and lateral
parabrachialnucleussendascendingconnectionstothePVN
and ARC [70–75]. Like the SFO, the neurons of the AP
are in direct contact with ghrelin and other hormones in
the circulation and communicate with autonomic control
centers.
There is already an established body of evidence describ-
ing the roles of two of the sensory CVOs: the subfornical
organ (SFO) and the area postrema (AP) in homeostatic
regulation. For example, the SFO is well known to regulate
ﬂuid balance via angiotensin II signaling, and AP is well
known to play critical roles in cessation of feeding via the
anorectic hormones: CCK and amylin (for reviews see [60,
76–78]). The remainder of this review will focus on the roles
ofSFOandAPintheprocessingofperipheralghrelinsignals.
7. Subfornical Organ Actions of Ghrelin
Some of the ﬁrst evidence that ghrelin may play a role in
regulation of energy balance by action at the SFO came in
2006 when Pulman et al. [45] demonstrated that the GHS-
R was expressed in SFO and that a subpopulation of SFO
neurons was dose dependently excited by the application
of exogenous ghrelin. The same study revealed that amylin,4 International Journal of Pediatrics
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(a)
10nM ghrelin 20mV
50 s
(b)
Figure 1: Ghrelin modulates the electrical activity of SFO neurons.
(a) Nissl-stained coronal section showing the SFO. (b) Repre-
sentative current-clamp recordings from dissociated SFO neurons
that were depolarized by application of 10nM ghrelin. This eﬀect
is mediated by activation of a cation conductance. Interestingly,
separate populations of SFO neurons depolarize in response to
either ghrelin or amylin (not shown). No SFO neurons are sensitive
to both ghrelin and amylin; see [45].
an anorexigenic peptide, also excited a subpopulation of
SFOneuronsandintriguinglythesubpopulationsofghrelin-
sensitive and amylin-sensitive neurons were mutually exclu-
sive (Figure 1). This suggested that orexigens and anorex-
igens both acted at the SFO, but via diﬀerent neuronal
pathways. These data are supported by the observation of
Takayama et al. [32] who observed increased c-Fos staining
in the SFO after peripheral ghrelin administration.
The SFO is classically thought of as a key CNS site
controlling thirst and drinking (for review see [77]), and
studies now also suggest that this CVO is a key site of
action for regulation of not only food but also water intake
by ghrelin. Two groups gave ICV injections of ghrelin into
rats and observed that while ghrelin increased food intake,
it also inhibited water intake [79, 80], eﬀects which were
also observed following peripherally injected ghrelin [81].
While ghrelin is primarily known for its actions on food
intake, these recent observations underscore the notion that
food and water intakes are both ingestive behaviors and are
inextricably linked (for review see [82]).
8. Area Postrema Actions of Ghrelin
Whileapotentialroleforghrelininregulatingenergybalance
at the AP has long been recognized (for review see [82,
83]), it has not received the same attention as the signaling
pathways including NPY/AGRP and POMC neurons within
theARC(forareviewofthenotionoftheARC-centricversus
distributed network hypotheses see [84]). The GHS-R is
expressed in the AP [9], strongly suggesting a role for ghrelin
in the regulation of AP neuronal function, a conclusion
supported by studies showing that peripheral administration
of ghrelin caused increases in c-Fos immunoreactivity in AP,
DMV, and NTS [32, 81, 85]. This result was not surprising
given the unfettered access of circulating ghrelin to AP
neurons. Importantly, ablation of AP resulted in the loss of
c-Fos immunostaining in DMV and NTS, suggesting that
ghrelin acts directly at the AP, while acting indirectly at the
DMN and NTS [85]. The eﬀect on c-Fos staining in ARC
afterAPlesionandperipheralinjectionofghreliniscurrently
unknown.
Peripheral injection of ghrelin can stimulate feeding
almost instantly [47]; therefore, the speed of the detection
of ghrelin signals is a point of interest. One may hypothesize
that the brainstem connection to ARC, in spite of being
polysynaptic, is probably faster and more consistent with
latency to feeding than to the ineﬃcient putative transport
of ghrelin across the BBB [47]. Unfortunately, there are not
suﬃcient c-Fos immunostaining data to compare the relative
time course for activation of AP and NTS to the activation of
ARC.
Recent observations by Gilg and Lutz [86] provide addi-
tional strong support for a central role for the AP in ghrelin-
mediated feeding. They observed that lesion of AP elimi-
nated ghrelin-induced feeding in two separate administra-
tion paradigms although an increase in body weight was still
observed, likely because of the ability of ghrelin to reduce fat
utilization [2]. This observation conclusively demonstrates
that ghrelin-induced feeding critically depends on intact
signaling at the AP. In further support of the notion that
the caudal brainstem plays a pivotal role in ghrelin-induced
feeding, Date et al. [58] carried out experiments lesioning
the midbrain of rats to destroy NTS-ARC projections. They
observed that the lesion abolishing communication between
the NTS and the hypothalamus eliminated both feeding
and c-Fos immunostaining in the ARC that are normally
induced after peripheral injection of ghrelin. Importantly,
in these studies feeding in response to ICV-administered
ghrelin remained intact after the midbrain lesion, showing
that hypothalamic and brainstem responses to ghrelin are
separable, yet linked. Date et al. [58]a r g u ei nf a v o ro fa
model where the vagus nerve detects ghrelin and transmits
this information to the ARC via noradrenergic projections
f r o mt h eN T S .T h er o l eo fv a g a la ﬀerent signaling has been
questioned by Arnold et al. [87] and the noradrenergic
nature of the NTS eﬀerents by Faulconbridge et al. [88].
Still, the Date model is not inconsistent with the possibility
that information regarding endogenous circulating ghrelin
gathered by AP and vagus is integrated within the NTS
then communicated to the ARC for further integration.
Clearly, the role of the AP and caudal brainstem cannot be
overlooked.
Another work provides strong support for the role of
the caudal brainstem in ghrelin-mediated feeding. Faulcon-
bridge et al. observed that direct injection of ghrelin intoInternational Journal of Pediatrics 5
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Figure 2: Ghrelin modulates the electrical activity of AP neurons.
(a) Nissl-stained coronal section showing the AP, along with
surrounding areas including NTS. ((b) and (c)) Representative
current-clamp recordings from dissociated AP neurons that were
depolarized or hyperpolarized by focally applied 10nM ghrelin.
The electrophysiological eﬀects were caused by activation of a
cation conductance (depolarization) or activation of K
+ current
(hyperpolarization); see [44].
the caudal brainstem elicits feeding at similar or lower
concentrations than required for ARC microinjections [89]
and that the food-stimulating doses in caudal brainstem do
not activate c-Fos in ARC [88]. The same group proposes a
strong contribution of caudal brainstem neurons expressing
NPY1 receptors [90]. While their data are not in complete
agreement with Date et al. [58] regarding the role of an
aminergic NTS connection to ARC, they do strongly support
the notion that caudal brainstem and ARC are ghrelin-
responsive areas with each contributing to ghrelin-mediated
feeding.
Towards understanding the role of AP in ghrelin signal-
ing, Fry and Ferguson [44] examined the sensitivity of AP
neurons to ghrelin using patch-clamp analysis. These exper-
iments demonstrated that about 40% of neurons within the
AP were sensitive to ghrelin, exhibiting changes in electrical
properties, and ﬁring rates when exposed to the hormone.
Intriguingly, half of these showed increased excitation, and
the other half showed reduced excitation in response to
application of physiologically relevant concentrations of
ghrelin(Figure 2).Theobservationthatcellscanbeinhibited
by ghrelin may suggest why some studies have not observed
an increase in c-Fos staining in the AP after administration
of ghrelin [31]. Further experiments to investigate the
projections and network properties of the ghrelin-sensitive
AP neurons are ongoing.
9. Conclusions
To reiterate, there is no doubt that ARC plays a role in
the regulation of energy balance by the hormone ghrelin.
However,therearesuﬃcientreasonstothinkthattheactivity
of ghrelin on energy balance may not be localized entirely to
the ARC but is distributed across diﬀerent brain regions. In
particular, the sensory CVOs are well positioned detecting
circulating ghrelin and passing this information to other
integrative centers for additional processing. Based on recent
observations, the sensory CVOs appear to play a crucial
role in the signaling pathways of ghrelin. Understanding the
interaction between the sensory CVOs, the ARC, and many
otherCNSnucleiimplicitlylinkedtotheregulationofenergy
balance will hopefully lead us towards developing successful
new strategies for the prevention and treatment of obesity.
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